(Q45868690)

17 December 2017

title

Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach (English)

1 reference

17 December 2017

0 references

3

1 reference

17 December 2017

Peggy Marconi

4

1 reference

17 December 2017

author name string

G Martino

1

1 reference

17 December 2017

P L Poliani

2

1 reference

17 December 2017

J C Glorioso

5

1 reference

17 December 2017

L Adorini

6

1 reference

17 December 2017

G Comi

7

1 reference

17 December 2017

language of work or name

1 reference

1 July 2000

1 reference

17 December 2017

Journal of Neuroimmunology

published in

1 reference

17 December 2017

volume

107

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

184-190

1 reference

17 December 2017

Impairment of TNF-receptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Ibuprofen does not suppress active multiple sclerosis lesions on gadolinium-enhanced MR images

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Cytokine gene expression in cells derived from CSF of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Development and application of herpes simplex virus vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Effector pathways in immune mediated central nervous system demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Interferon-gamma confers resistance to experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Replication-defective herpes simplex virus vectors for gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Immunopathogenesis of multiple sclerosis: the role of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Tumor necrosis factor alpha and its receptors in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Treatment of multiple sclerosis with copolymer-1 (Copaxone): implicating mechanisms of Th1 to Th2/Th3 immune-deviation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin-4 production and associated eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years. The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900236-8

7 January 2021

10.1016/S0165-5728(00)00236-8

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017